Frontiers in Oncology

429.6k citations
29.4k papers · · active since 1950

Impact in

    • Cancer-related molecular mechanisms research
    • MicroRNA in disease regulation
    • Cancer, Hypoxia, and Metabolism
  • Oncology top 0.5%
    • Cancer Immunotherapy and Biomarkers
    • Cancer Cells and Metastasis

Papers in

    • Cancer-related molecular mechanisms research 1.5k
    • Cancer, Hypoxia, and Metabolism 936
    • Cancer Genomics and Diagnostics 925
    • Cancer Immunotherapy and Biomarkers 1.5k

Frontiers in Oncology

22.8k papers receiving 396.0k citations

Peers

Frontiers in Oncology
Comparison fields: 5 of 237
  • Cancer Research 77.6k
  • Oncology 105.5k
  • Pulmonary and Respiratory Medicine 67.8k
  • Immunology 44.5k
  • Molecular Biology 146.7k
Replace Cancers with:
Cancers United States
BMC Cancer China
The Lancet Oncology United States
European Journal of Cancer United Kingdom
The Journal of Pathology United Kingdom
Nature reviews. Cancer United States
Journal of Clinical Pathology United Kingdom
Cancer Letters United States
Annals of Oncology United States
BioMed Research International China
Frontiers in Oncology relative to Cancers United States Cancers's profile →
Citations per field
00.5×1.5×1.8×
Cancers · 1×
Citations per year

Countries where authors publish in Frontiers in Oncology

Since Specialization
Citations

This map shows the geographic impact of research published in Frontiers in Oncology. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers published in Frontiers in Oncology with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frontiers in Oncology more than expected).

Fields of papers published in Frontiers in Oncology

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers published in Frontiers in Oncology. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers published in Frontiers in Oncology.

About Frontiers in Oncology

The 29.4k papers published in Frontiers in Oncology in the last decades have received a total of 429.6k indexed citations . Papers published in Frontiers in Oncology usually cover Cancer Research (4.6k papers), Oncology (7.6k papers), Pulmonary and Respiratory Medicine (5.6k papers), Genetics (1.5k papers) and Otorhinolaryngology (563 papers) specifically the topics of Cancer Immunotherapy and Biomarkers (1.5k papers), Cancer-related molecular mechanisms research (1.5k papers), RNA modifications and cancer (1.2k papers), Ferroptosis and cancer prognosis (1.0k papers), Glioma Diagnosis and Treatment (981 papers), Cancer, Hypoxia, and Metabolism (936 papers), Cancer Genomics and Diagnostics (925 papers) and Lung Cancer Treatments and Mutations (911 papers). The most active scholars publishing in Frontiers in Oncology are Mohit Kumar Jolly, Silvia C. Formenti, Camillo Porta, Chiara Paglino, Alessandra Mosca, Katherine E. Warren, Kentaro Inamura, Martin Augsten, Judith A. Seidel and Kenji Kabashima.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore journals with similar magnitude of impact